StockNews.AI
SRTS
StockNews.AI
2 days

Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm

1. Portnoy Law Firm initiates investigation into Sensus for possible securities fraud. 2. Sensus reported a Q2 2025 EPS loss of $0.06, missing estimates. 3. Revenue of $7.3 million represents a 20.7% year-over-year decline. 4. Stock price dropped 35.3% after disappointing earnings report. 5. Investors may pursue claims to recover losses from the firm.

3m saved
Insight
Article

FAQ

Why Bearish?

The substantial earnings miss and revenue drop are likely to weigh heavily on investor sentiment, reminiscent of past declines faced by companies under similar scrutiny for revenue declines.

How important is it?

The article highlights significant issues for SRTS, including financial underperformance and potential legal ramifications, which are crucial for investor sentiment.

Why Short Term?

Immediate market reaction to earnings and potential class action will likely affect SRTS stock over the next few months. Similar cases have often shown declines lasting until new positive developments emerge.

Related Companies

SRTSSPYIWMQQQ
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sensus Healthcare, Inc. (“Sensus” or “the Company”) (NASDAQ: SRTS) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Sensus investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses. On August 7, 2025, Sensus reported its financial results for the second quarter of 2025, disclosing a GAAP earnings-per-share loss of $0.06, missing analyst estimates by $0.09, and revenue of $7.3 million, a decline of 20.7% year-over-year and below estimates by $2 million. Sensus attributed the revenue decline primarily to a reduction in units sold to a large customer, partially offset by growth in recurring revenue from Fair Deal Agreements. On this news, the price of Sensus stock declined $1.89 per share, or approximately 35.3%, to close at $3.46 per share on August 8, 2025, thereby injuring investors. Please visit our website to review more information and submit your transaction information. The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. Lesley F. Portnoy, Esq.Admitted CA, NY and TX Barslesley@portnoylaw.com310-692-8883www.portnoylaw.com Attorney Advertising

Related News